The Valeant Debt Story |
November 02, 2015 | November 2015 Bond Updates |
Valeant Pharmaceuticals International, Inc. (VRX) has been a focal point for Wall Street for the past week with dueling reports and conference calls captivating investor's attention. |
View more at: http://www.forbes.com/sites/petertchir/2015/11/01/the/ |
Related News |
|